Datavault AI Inc. provides data monetization, credentialing, digital engagement and real-world asset tokenization technologies through a cloud-based platform spanning Acoustic Sciences and Data Sciences. Its recurring announcements describe AI-driven data experiences, asset valuation and monetization, Information Data Exchange® capabilities for Digital Twins and name, image and likeness licensing, and patented audio technologies including WiSA, ADIO and Sumerian.
Company news also covers registered equity offerings, use of proceeds for a quantum-ready GPU edge network, financial-results communications, and material agreements tied to tokenized assets and exchange technology. Updates often connect Datavault AI's common stock capital structure with product deployment, licensing, analytics, marketing automation and industry applications in sports and entertainment, education, fintech, healthcare, energy and other markets.
Summary not available.
Datavault AI (Nasdaq: DVLT) announced a partnership with Rodney’s Comedy Club on November 6, 2025 to integrate VerifyU credentials, Joke Token, and ADIO® data-over-sound technology into live comedy shows.
The collaboration enables verifiable performer and fan credentials, real-time joke copyrighting and valuation, blockchain-based fan rewards, and data-rich “joke tokens” that can be licensed or sold to ticket holders and creators. The platform aims to create recurring revenue through credential issuance, token transactions, and engagement analytics as it scales across venues.
Datavault AI (Nasdaq: DVLT) granted a worldwide exclusive license with sublicense rights to Scilex (Nasdaq: SCLX) for Datavault AI's AI-driven tokenization and data-monetization technology tailored to biotech and biopharma.
Key terms: a $10.0 million nonrefundable upfront license fee payable in four equal installments through Sept 30, 2026, plus up to $2.55 billion in sales milestone payments. The license covers tokenization of genomic/DNA data, diagnostics, therapeutics, genetic and drug information and cites an estimated $2.0 trillion tokenization opportunity in pharmaceutical and diagnostic sales.
The deal highlights Datavault AI's issued and pending patents, including a pending patent for tokenizing DNA data (U.S. App. No. 17/941,623), and builds on prior AI collaborations.
Datavault AI (Nasdaq: DVLT) on November 3, 2025 announced a collaboration with NFHITS and Music Dash to build a Web 3.0 minting and blockchain-based music and content distribution network.
The partnership will integrate Datavault AI’s Datavalue, DataScore, Data Vault Bank, VerifyU, ADIO and NYIAX-powered exchange features to mint music assets, authenticate artists/rights, protect royalties, reduce piracy, and enable digital collectibles and objectified music assets across major platforms.
The companies plan to deploy inaudible ADIO tone delivery across venues and retail channels and leverage NFHITS’ existing distribution footprint to create new monetization streams for artists.
Datavault AI (NASDAQ: DVLT) announced a one-time distribution of the Dream Bowl 2026 Meme Coin to DVLT and Scilex shareholders of record on Nov. 14, 2025, subject to board approval. Tokens will be airdropped to Data Vault® wallets following final roster confirmations on or after Nov. 25, 2025. The Dream Bowl event is scheduled for Jan. 11, 2026 at AT&T Stadium in Dallas and will include college football, drone racing, and e-sports championships. Tokens include utility features such as immutable ownership, embedded ticketing, and exclusive event content.
Datavault AI (NASDAQ: DVLT) issued a formal rebuttal to a Wolfpack Research short report it calls false and defamatory, announcing retained counsel and intent to pursue litigation and regulatory remedies. The Company reaffirmed its strategic focus on a patent-backed technology stack for data tokenization, AI-driven valuation, inaudible audio signal tech, and enterprise monetization, citing more than 70 U.S. and international patents and recent commercial milestones including acquisitions, partnerships, product launches, and planned data-exchanges.
Datavault AI (Nasdaq: DVLT) announced it has entered into a definitive agreement to acquire API Media in an all-cash transaction expected to close in December 2025. The deal keeps the API brand and aims to combine Datavault’s patented data tokenization and monetization technologies with API’s audio/visual and event-focused solutions.
The companies say the acquisition will expand Datavault’s AI-powered capabilities, broaden its recurring-revenue base, and enhance enterprise data activation, audience intelligence, and revenue analytics across global markets.
Datavault AI (Nasdaq: DVLT) announced a definitive global licensing agreement with Nature's Miracle (OTCQB: NMHI) dated October 28, 2025 to license Datavault AI's patented Carbon Credit Tokenization System.
Under the deal Datavault AI will receive a $2,000,000 non-refundable license fee plus a 35% royalty on all gross revenue generated from the licensed technology. The license grants worldwide rights for the life of the listed patents and targets blockchain-powered carbon credit tokenization, VerifyU credentialing, and ADIO data monetization, with commercial focus in Asia including Japan, Taiwan, and South Korea.
Datavault AI (Nasdaq: DVLT) announced on October 27, 2025 the launch of two data unions: an Insurance Data Union partnering with the Independent Insurance Agents & Brokers of America (Big "I") and independent agents, and an Accounting Data Union partnering with the top two private accounting firms from each U.S. state.
The unions will tokenize anonymized insurance and accounting data using Datavault AI's patented technologies (including U.S. Patent Nos. 12,198,201, 11,315,150, and 11,593,515) and pending applications to enable wallet-based tokens, smart-contract payments, and scalable monetization. The company cites total addressable markets of $8 trillion insurance and $650 billion accounting as opportunity backdrops.
DataVault AI (NASDAQ: DVLT) and Wellgistics Health (NASDAQ: WGRX) entered a SAAS smart‑contract services agreement to develop PharmacyChain™, a manufacturer‑to‑patient blockchain tracking and dispensing platform targeting the $639 billion prescription drug market. The companies expect to finalize a profit‑sharing license in Q4 2025 and begin beta testing in H1 2026. DataVault AI cites issued U.S. patents dated April 16, 2024; June 25, 2024; and September 24, 2024 that it says cover blockchain, token‑driven data monetization and related IP. Management cites early inbound interest from manufacturers, pharmacists and insurers and describes plans for opt‑in biometric/diagnostic data and utility token monetization to enable new revenue streams.